# Monopar Therapeutics: Form 8-K, filed Mar 23, 2023

- Company: [Monopar Therapeutics](/companies/mnpr.md) (CIK 1645469)
- Form: 8-K
- Filed: 2023-03-23
- Accepted by EDGAR: Mar 23, 2023, 07:03 ET
- Period: 2023-03-23
- Accession: 0001654954-23-003383
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1645469/000165495423003383/mnpr_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1645469/000165495423003383/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1645469/000165495423003383/mnpr_8k.htm

Filed Mar 23, 2023.
Source: SEC EDGAR, the filing index for accession 0001654954-23-003383. Last ingested by Listed: Nov 12, 2026, 18:09 ET. No prices; not investment advice.
